USPTO trademark

NEUROGEN DIRECT

AllowedUSPTOWord markClass 35Class 44

"NEUROGEN DIRECT" is a word mark owned by Neurogen Biomarking, LLC, filed at the USPTO on April 9, 2025. It has been allowed and covers classes 35 and 44.

Official USPTO record
NEUROGEN DIRECT trademark as filed
As filed with the USPTO
Status
Allowed
Since July 14, 2026
Filed
April 9, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99128124
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns NEUROGEN DIRECT

The owner and representative on file with the office.

Owner

Neurogen Biomarking, LLC

Dover, United States

Representative

Bailey Ann Cremeans

Epstein Becker Green

Goods and services

What the mark covers

The products and services NEUROGEN DIRECT is filed for, grouped by Nice class.

  • Maintaining a registry of primary care physicians who meet established standards for understanding and utilizing specialized screening test kits; business administrative services for medical referrals featuring primary care physicians trained in the use of screening services for neurological disease indicators

  • Providing an online computer database featuring health information pertaining to primary care physicians who meet established standards for understanding and utilizing specialized screening test kits

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Teas/email correspondence entered
  7. Correspondence received in law office
  8. Teas response to office action received
  9. Notification of non-final action e-mailed
  10. Non-final action e-mailed

5 earlier steps on the official record.

FAQ

About NEUROGEN DIRECT

Who owns the trademark "NEUROGEN DIRECT"?

The USPTO trademark "NEUROGEN DIRECT" (application 99128124) is owned by Neurogen Biomarking, LLC.

What is the status of "NEUROGEN DIRECT"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NEUROGEN DIRECT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2aa8-4309-730f-8555-d9eee6b9b486
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2aa8-4309-730f-8555-d9eee6b9b486",
  "object": "trademark",
  "mark_text": "NEUROGEN DIRECT",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99128124",
  "filing_date": "2025-04-09",
  "nice_classes": [
    35,
    44
  ],
  "owners": [
    {
      "name": "Neurogen Biomarking, LLC",
      "entity_id": null
    }
  ]
}